Man who defrauded biotech company of 840,000 jailed for over three years
Adrianus Kees pled guilty to fraud that involved a scheme to extract funds from Ovagen under the guise of securing a loan.
Leiden-based biotech company VitroScan secures 1.9M from National Growth Fund's Biotech Booster program - Silicon Canals
VitroScan secures €1.9M funding to enhance chemotherapy response prediction for ovarian cancer patients, preparing for clinical application.
Biotech Booster aims to commercialize biotechnology research through funding, mentorship, and collaboration.
10 Major North Carolina Industries to Consider if You're Working in or Moving to the Tar Heel State
North Carolina offers diverse career opportunities in thriving industries like biotechnology and IT, making it attractive for job seekers and homebuyers.
Electrostatic Pollen is an artificial system that broadcasts plant genetic material using solar energy, creating a digital legacy for peach trees.
BaCta is using engineered bacteria to grow natural rubber and slash CO2 emissions | TechCrunch
baCta is engineering bacteria to produce sustainable natural rubber, addressing environmental concerns and commercialization challenges in the rubber industry.
Faircraft raises 15M to develop lab-grown leather - Silicon Canals
Faircraft secures €15M funding to scale production of lab-grown leather.
The startup aims to meet rising demand through team expansion and innovative processes.
From pond scum to premium skincare? Deep Blue Biotech is all in on blue-green algae to make better chemicals | TechCrunch
Deep Blue Biotech is revolutionizing chemical production through sustainable biomanufacturing using engineered cyanobacteria, aiming for both cost parity and environmental benefits.
Biorecycling CEO displays a jacket made from pollution but says people still don't believe it's real or even possible
LanzaTech turns pollution into products, highlighting innovative solutions for climate challenges despite industry skepticism.
Electrostatic Pollen is an artificial system that broadcasts plant genetic material using solar energy, creating a digital legacy for peach trees.
BaCta is using engineered bacteria to grow natural rubber and slash CO2 emissions | TechCrunch
baCta is engineering bacteria to produce sustainable natural rubber, addressing environmental concerns and commercialization challenges in the rubber industry.
Faircraft raises 15M to develop lab-grown leather - Silicon Canals
Faircraft secures €15M funding to scale production of lab-grown leather.
The startup aims to meet rising demand through team expansion and innovative processes.
From pond scum to premium skincare? Deep Blue Biotech is all in on blue-green algae to make better chemicals | TechCrunch
Deep Blue Biotech is revolutionizing chemical production through sustainable biomanufacturing using engineered cyanobacteria, aiming for both cost parity and environmental benefits.
Biorecycling CEO displays a jacket made from pollution but says people still don't believe it's real or even possible
LanzaTech turns pollution into products, highlighting innovative solutions for climate challenges despite industry skepticism.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.
# Penny Stocks to Buy With $100
Penny stocks can be risky but offer significant potential returns if chosen wisely.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.
# Penny Stocks to Buy With $100
Penny stocks can be risky but offer significant potential returns if chosen wisely.
Scavengers recycle organic matter, helping ecosystems by feeding on waste, and are studied for their unique adaptations to consuming decaying food safely.
As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data
23andMe is restructuring, laying off 40% of its workforce, and abandoning its therapeutics program amidst severe financial struggles.
Prioritizing healthspan is essential for living a long, healthy life, and current research and innovation are paving the way for revolutionary aging solutions.
The Quest for Immortality: What Do Scientists Say?
Advancements in biotechnology, AI, and regenerative medicine bring humanity closer to understanding and potentially extending life indefinitely.
NYC company develops simple swab test that can tell how well you're aging
CheekAge is an innovative aging clock that predicts biological age from cheek cells, offering a non-invasive alternative to traditional blood tests.
Saliva swab could predict if you'll die within the year
A cheek swab test can estimate the risk of dying in a year by analyzing DNA changes, potentially indicating biological age.
Why Sleep Is the Key to Living Longer
Prioritizing healthspan is essential for living a long, healthy life, and current research and innovation are paving the way for revolutionary aging solutions.
The Quest for Immortality: What Do Scientists Say?
Advancements in biotechnology, AI, and regenerative medicine bring humanity closer to understanding and potentially extending life indefinitely.
NYC company develops simple swab test that can tell how well you're aging
CheekAge is an innovative aging clock that predicts biological age from cheek cells, offering a non-invasive alternative to traditional blood tests.
Saliva swab could predict if you'll die within the year
A cheek swab test can estimate the risk of dying in a year by analyzing DNA changes, potentially indicating biological age.
Automation and robotics are revolutionizing the efficiency of microbial processes in research by drastically increasing throughput and reducing manual errors.
Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers
Ossium Health is pioneering stem cell transplants from deceased donors, addressing the donor shortage for blood cancer patients, particularly minorities.
Cutting-edge CAR-T cancer therapy is now made in India - at one-tenth the cost
Indian biotech company produces affordable CAR-T therapy
Promise of CAR-T therapy in treating cancer and autoimmune diseases
Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers
Ossium Health is pioneering stem cell transplants from deceased donors, addressing the donor shortage for blood cancer patients, particularly minorities.
Cutting-edge CAR-T cancer therapy is now made in India - at one-tenth the cost
Indian biotech company produces affordable CAR-T therapy
Promise of CAR-T therapy in treating cancer and autoimmune diseases
In other news this week: Knave secures 225M, London-based Purespring raises 95M, VERBUND X Ventures invests in Ausrtia's Easelink, and more - Silicon Canals
Tech innovations in October highlighted significant funding rounds for companies like Knave, Purespring, and Basecamp Research.
In other news this week: Nattergal raises 48M, Otoqi's 10M Series B, Wolt acquires Tazz, Netherlands gets its first PE community, and more - Silicon Canals
Innovative stories often get lost in the fast-paced news cycle, highlighting the importance of platforms dedicated to lesser-known updates.
Dutch biotech company Phlox Therapeutics raises 1.9M
Phlox Therapeutics has successfully raised €1.9M to advance RNA therapies targeting genetic laminopathies and cardiomyopathies.
In other news this week: Knave secures 225M, London-based Purespring raises 95M, VERBUND X Ventures invests in Ausrtia's Easelink, and more - Silicon Canals
Tech innovations in October highlighted significant funding rounds for companies like Knave, Purespring, and Basecamp Research.
In other news this week: Nattergal raises 48M, Otoqi's 10M Series B, Wolt acquires Tazz, Netherlands gets its first PE community, and more - Silicon Canals
Innovative stories often get lost in the fast-paced news cycle, highlighting the importance of platforms dedicated to lesser-known updates.
Dutch biotech company Phlox Therapeutics raises 1.9M
Phlox Therapeutics has successfully raised €1.9M to advance RNA therapies targeting genetic laminopathies and cardiomyopathies.
Biological Deposits in Patent Applications: Why, When and Where
The Budapest Treaty simplifies the patent application process for biological inventions by requiring one deposit to fulfill multiple jurisdictional obligations.
The PTAB upheld a utility patent for a maize variety developed through simple crossbreeding, emphasizing the importance of genotypic considerations in patent claims.
Biological Deposits in Patent Applications: Why, When and Where
The Budapest Treaty simplifies the patent application process for biological inventions by requiring one deposit to fulfill multiple jurisdictional obligations.
The PTAB upheld a utility patent for a maize variety developed through simple crossbreeding, emphasizing the importance of genotypic considerations in patent claims.
The Israel-Hamas conflict one year on: researcher resilience in the face of war
Hussein Al-Ajrami, displaced due to conflict, is now developing sustainable shelters for Palestinian families in partnership with a non-profit organization.
We Need to be Ready for Biotech's ChatGPT Moment
Biology will revolutionize industries like healthcare, food production, and energy with advancements such as lab-grown meat, personalized therapies, and AI-driven biological experiments.
The Israel-Hamas conflict one year on: researcher resilience in the face of war
Hussein Al-Ajrami, displaced due to conflict, is now developing sustainable shelters for Palestinian families in partnership with a non-profit organization.
We Need to be Ready for Biotech's ChatGPT Moment
Biology will revolutionize industries like healthcare, food production, and energy with advancements such as lab-grown meat, personalized therapies, and AI-driven biological experiments.
Addgene streamlines the sharing of plasmids to facilitate research and collaboration in the life sciences.
A snapshot of Lithuania's life-sciences landscape
Lithuania aims to enhance research in life sciences and biotechnology by retaining local talent, attracting international researchers, and promoting collaboration over competition.
Twenty years of Addgene
Addgene streamlines the sharing of plasmids to facilitate research and collaboration in the life sciences.
A snapshot of Lithuania's life-sciences landscape
Lithuania aims to enhance research in life sciences and biotechnology by retaining local talent, attracting international researchers, and promoting collaboration over competition.
Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024
Market pullbacks can make investors hesitant, but undervalued opportunities exist in the pharmaceutical and biotechnology sectors, with some stocks predicted to double in value.
Check Out Last Week's Big Insider Buying: Biotechs, Energy, and More
Recent insider buying activity signals confidence in stock price increases, especially in biotech and during market uncertainties.
Stock Market Today: The Biggest Premarket Winners and Losers
Premarket trading can reveal significant movements in stock prices based on news and developments.
3 Hot Penny Stocks to Buy With $1000
Penny stocks are risky investments that can lead to significant gains if chosen wisely.
Investors should be cautious and only invest money they can afford to lose in penny stocks.
Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024
Market pullbacks can make investors hesitant, but undervalued opportunities exist in the pharmaceutical and biotechnology sectors, with some stocks predicted to double in value.
Check Out Last Week's Big Insider Buying: Biotechs, Energy, and More
Recent insider buying activity signals confidence in stock price increases, especially in biotech and during market uncertainties.
Stock Market Today: The Biggest Premarket Winners and Losers
Premarket trading can reveal significant movements in stock prices based on news and developments.
3 Hot Penny Stocks to Buy With $1000
Penny stocks are risky investments that can lead to significant gains if chosen wisely.
Investors should be cautious and only invest money they can afford to lose in penny stocks.
Penny stocks can yield significant returns but come with high risk; only invest what you can afford to lose.
4 Stocks Under $5 To Buy Now
Penny stocks below $5 come with higher risk but potential for significant gains, particularly in biotechnology investments.
Penny Stocks To Buy With Just $1500: PMVP, BOLD, SPRO
Investing in penny stocks offers the potential for high returns, but comes with significant risks, particularly in the domain of small, undeveloped companies.
3 Penny Stocks to Buy With $500
Penny stocks can yield significant returns but come with high risk; only invest what you can afford to lose.
4 Stocks Under $5 To Buy Now
Penny stocks below $5 come with higher risk but potential for significant gains, particularly in biotechnology investments.
Penny Stocks To Buy With Just $1500: PMVP, BOLD, SPRO
Investing in penny stocks offers the potential for high returns, but comes with significant risks, particularly in the domain of small, undeveloped companies.
A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-Up
The discovery of a gene controlling prickliness can lead to the development of smooth, prickle-free plants without compromising fruit and flower quality.
Author Correction: Birth of protein folds and functions in the virome - Nature
The article highlights the significance of interdisciplinary collaboration in advancing biotechnological research.
A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-Up
The discovery of a gene controlling prickliness can lead to the development of smooth, prickle-free plants without compromising fruit and flower quality.
Author Correction: Birth of protein folds and functions in the virome - Nature
The article highlights the significance of interdisciplinary collaboration in advancing biotechnological research.
Common food dye found to make skin and muscle temporarily transparent
A food dye can make animal tissues temporarily transparent, enhancing visibility for medical applications.
Harnessing the power of technology to better meet patient needs
The urgency of increasing plasma donations drives a need for digital transformation in plasma-derived therapies.
AirBubble Restorative Space / ecoLogicStudio
The AirBubble design promotes employee well-being through a blend of nature and advanced biotechnological solutions.
An Interview about the Sentient Clit | Berlin Art Link
The 'Sentient Clit' project explores female pleasure through bioprinted clitorises from menstrual blood, merging art, science, and social critique.
Who wins from nature's genetic bounty? The billions at stake in a global biopiracy' battle
The ownership and distribution of genetic data from biodiversity is a crucial issue being discussed at upcoming international summits.
Adaptive 3D printing system to pick and place bugs and other organisms
The University of Minnesota has developed an adaptive 3D printing system that can autonomously identify and manipulate organisms for various applications, streamlining research processes.
Never underestimate RNA: how a molecule went from bit player to star of the show
RNA is a multifaceted player in evolution and cell biology, with diverse functions beyond just genetic information.
Embark On A Climate-conscious Expedition with Positive Polar
Pioneering polar expedition company intertwines luxury travel with environmental stewardship.
Swiss startup creates modular device for on-demand cell therapy manufacturing
Automated cell therapy manufacturing with less stress and contamination through modular device.
Powerful 'nanopore' DNA sequencing method tackles proteins too
Protein analysis using nanopore sequencing is advancing, enabling the identification of proteins and their modifications without exact amino acid sequencing.
New AI can CHANGE human genes to cure even the rarest of diseases
AI-designed gene editing system OpenCRISPR-1 reduces off-target editing by 95%, offering potential for precise genetic disease cures.
Net art pioneer Shu Lea Cheang wins $100,000 LG Guggenheim prize
Shu Lea Cheang wins LG Guggenheim Award with $100,000 prize for her work with technology
Cheang's diverse projects span biotechnology, alternative currencies, and gender perceptions